Results 161 to 170 of about 30,573 (214)

Synchronous primary pulmonary extranodal NK/T-cell lymphoma and relapsed Hodgkin lymphoma occurring after chemotherapy for primary Hodgkin lymphoma: A case report and literature review. [PDF]

Rare Tumors
Corredor-Orlandelli D, Bohórquez L, Arévalo-Zambrano M.   +2 more
europepmc   +1 more source

Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing? [PDF]

Blood Res
Yoon SE, Cho J, Kim HY, Kim SJ, Kim WS.
europepmc   +1 more source

Characterization and Optimization of L-Asparaginase Production by <i>Endophytic Fusarium</i> sp3 Isolated From <i>Malcolmia aegyptiaca</i> of Southeast Algeria: Potential for Acrylamide Mitigation in Food Processing. [PDF]

Food Sci Nutr
Lakhdari W, Neghmouche Nacer S, Benyahia I, Hammi H, Bachir H, Mouhoubi D, Lakhdari Y, Guemmou I, Dehliz A, Sawicka B, Ahmad SF, Attia SM, Djemoui A, Messaoudi M.   +13 more
europepmc   +1 more source

Acute lymphoblastic leukemia: an update on treatment and Brazilian perspective. [PDF]

Front Oncol
Correa BT, Silva GSS, Mendes WJS, Soares LL, Lima JA, Pereira CGS, de Souza JVT, Dos Santos MEF, Aleluia ACM, da Guarda CC, Póvoas RQS, Gonçalves MS, Aleluia MM.   +12 more
europepmc   +1 more source

Biogeneric native and polyethylene glycol-conjugated E. coli asparaginases for treating children with acute lymphoblastic leukaemia

Datta N, Jana B, Goswami S, Roy A, Samaddar S, Kundu S, Gogoi MP, Dasgupta B, Dutta T, Das N, Saha V, Sidhu J, Krishnan S.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PEG-asparaginase

Expert Opinion on Pharmacotherapy, 2007
L-asparaginases have been established components in the treatment of acute leukemias for nearly 40 years. Their antitumor effect results from the depletion of asparagine, an amino acid essential to leukemic cells, and subsequent inhibition of protein synthesis leading to considerable cytotoxicity.
Cecilia H, Fu, Kathleen M, Sakamoto
openaire   +2 more sources

Asparaginase revisited

Leukemia & Lymphoma, 2011
Asparaginase is one of the main drugs used to treat acute lymphoblastic leukemia and certain non-Hodgkin lymphomas. The drug is a bacterial product, and this results in differences in activity, efficacy, and side effects among the various marketed products. Native products originate from either Escherichia coli or Erwinia chrysanthemi.
openaire   +2 more sources

L-Asparaginase

Annual Review of Medicine, 1970
R L, Capizzi, J R, Bertino, R E, Handschumacher   +2 more
openaire   +4 more sources

Asparaginase

Reactions Weekly, 2013
  +6 more sources